What Does Bollinger Band say about Neos Therapeutics, Inc. (NASDAQ:NEOS)?


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Neos Therapeutics, Inc. (NASDAQ:NEOS) for the period of 9-Day stands at 7.31% while the stochastic %D for the same period stands at 9.99%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Neos Therapeutics, Inc. (NASDAQ:NEOS) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for Neos Therapeutics, Inc. (NASDAQ:NEOS) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently Neos Therapeutics, Inc. (NASDAQ:NEOS)’s 20-Day Bollinger Band indicates “Sell”.

About Company

Neos Therapeutics, Inc. is engaged in developing, manufacturing and commercializing products for the treatment of attention deficit hyperactivity disorder using drug delivery technologies. Its product candidates include NT-0102 methylphenidate XR orally disintegrating tablet for the treatment of ADHD; NT-0202 amphetamine XR orally disintegrating tablet for the treatment of ADHD; NT-0201 amphetamine XR liquid suspension for the treatment of ADHD and Generic Tussionex, which are in different clinical development stage. Neos Therapeutics, Inc. is headquartered in Grand Prairie, Texas.

Previous Day Activity Analysis

On the last trading day, Neos Therapeutics, Inc. (NASDAQ:NEOS) opened the session at $8.2 and after going down -6.79% closed at $7.55. The stock lost -0.65 points in the last trade.

Neos Therapeutics, Inc. (NASDAQ:NEOS)’s stock fluctuated in the range of $7.50 and $8.20 during the previous active session. Neos Therapeutics, Inc. (NASDAQ:NEOS) traded with the volume of 1.36 Million with average volume of 598.53 Million. The stock has HIGH volatility on the last trading session.

Currently the Beta for the company remains at 0 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.42 and 34.84 respectively.

Currently the Insider Ownership of the shares of Neos Therapeutics, Inc. (NASDAQ:NEOS) is at 0.8% and the shares outstanding are 29.61 Million.

Important Ratio Analysis

Some important ratios to consider here for Neos Therapeutics, Inc. (NASDAQ:NEOS) are discussed below:

The Price to Sale P/S and Price to Book P/B shows the value of 14.33 and 6.74 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 2.84 and 0 correspondingly.

The Quick Ratio of Neos Therapeutics, Inc. (NASDAQ:NEOS) stands at 2.8 while the Current Ratio depicts the value of 3.

Return on Assets ROA of Neos Therapeutics, Inc. (NASDAQ:NEOS) is at -81% whereas, Return on Equity ROE and Return of Investment ROI of Neos Therapeutics, Inc. (NASDAQ:NEOS) stand at -611.7% and -125.2% respectively.

Stock Performance Analysis

The stock performance of Neos Therapeutics, Inc. (NASDAQ:NEOS) on the basis of 5 day trade show the dip of -14.2% whereas, the monthly performance of the stock shows decrease of -10.12%.

The quarterly performance of the stock remained in green zone with the value of 11.85% while six month performance of the shares of Neos Therapeutics, Inc. (NASDAQ:NEOS) remained bullish with the count of 8.63%.

The yearly and YTD performance of Neos Therapeutics, Inc. (NASDAQ:NEOS) remained up at 20.41% and 29.06% respectively.